Polarean Imaging enters contract with University of British Columbia
Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.
The AIM-traded firm said UBC had received financial support from the Canada Foundation for Innovation, which had also been active in supporting pulmonary imaging research using hyperpolarised ‘129Xe’ technology in the Toronto area and specifically, the SickKids Hospital in Toronto.
“We are excited to welcome doctors Sin and Leipsic and the staff of UBC to our expanding base of collaborative researchers and look forward to assisting them in achieving the goals of their research programme,” said Polarean Imaging chief executive officer Richard Hullihen.
“UBC has a long history and pioneering reputation in the field of medical imaging research and I look forward to providing further updates regarding our collaboration with UBC as appropriate.
“The company's management team is excited to see the continued scientific and clinical evolution of hyperpolarized xenon imaging in medicine and to assist in providing our equipment to researchers in order to push these important frontiers.”